Sterile inflammation in thoracic transplantation

Area of Science:

• Transplantation immunology
• Inflammation biology
• Surgical pathology

Background:

• Allograft dysfunction post-transplantation is frequently driven by infectious and sterile inflammation.
• Sterile inflammation, characterized by damage-associated molecular patterns (DAMPs) and alarmins release, perpetuates cellular injury and graft damage.
• Ischemia-reperfusion injury (IRI) is a major cause of sterile inflammation in organ transplantation, leading to poor outcomes.

Purpose of the Study:

• To review the common and distinct mechanistic pathways of post-transplant sterile inflammation.
• To identify potential therapeutic targets for mitigating sterile inflammation and allograft dysfunction.
• To bridge the gap between understanding sterile inflammation and developing personalized treatments.

Main Methods:

• Literature review of studies on sterile inflammation in organ transplantation.
• Analysis of signaling cascades involved in damage-associated molecular patterns (DAMPs) and alarmin-mediated inflammation.
• Comparative analysis of sterile inflammation pathways in heart and lung transplantation.

Main Results:

• Sterile inflammation involves conserved signaling pathways across different organs and species.
• Ischemia-reperfusion injury (IRI) significantly contributes to the cycle of sterile inflammation and cellular damage.
• Current non-specific therapies offer moderate benefits, highlighting the need for targeted approaches.

Conclusions:

• A deeper mechanistic understanding of sterile inflammation is crucial for advancing transplantation outcomes.
• Identifying specific pathways offers opportunities for developing personalized and effective therapies.
• Targeting sterile inflammation pathways holds promise for preventing allograft dysfunction and improving graft survival.